Developing a Culture of Pharmacovigilance

Posted by:

Today Pugatch Consilium launches Developing a Culture of Pharmacovigilance. Authored by Professor Meir Pugatch, Dr David Torstensson and Ma’ayan Laufer this report examines one of the most important facets of a high quality drug regulatory structure, namely that of pharmacovigilance.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span – from test tube to patient. As patients and healthcare professionals around the world access and ...

Continue Reading →
0

Understanding the drivers of biopharmaceutical clinical research: Why do some countries get all the investment?

Posted by:

Today Pugatch Consilium releases Scaling Up Global Clinical Trial Activity: Key Trends and Policy Lessons. This study uses regression analysis of data on 50 countries to provide a roadmap for creating a policy environment that is conducive to clinical trials. The study also benchmarks performance in the level of scope of clinical trial activity.
The main messages of the report are:

  • The creation of a pro-innovation culture is just as, if not more, important as improvements to health system capacity for ...
Continue Reading →
0

The Creative Industries and the BRICS – full report is now available on our site!

Posted by:

A review of the state of the creative economy in Brazil, Russia, India, China and South Africa

This review examines the state of the creative economy in the biggest emerging economies in the world namely Brazil, Russia, India, China and South Africa – the BRICS. Although at different levels of development, these economies are in many ways undergoing similar transitions from economies based on manufacturing, industrial output and natural resources to economies in which economic activity is ...

Continue Reading →
0

Dr David Torstensson speaks on clinical trials transparency at American Chamber of Commerce to the EU in Brussels

Posted by:

Pugatch Consilium Partner, Dr Torstensson presented the main findings of the Pugatch Consilium report Heading in a Different Direction? The European Medicines Agency’s Policy on the Public Release of Clinical Trials Data at the report’s EU launch. The launch took place at the AmCham EU offices in Brussels, Belgium.

The report was commissioned by the US Chamber of Commerce’s GIPC. It examines the debate and policies in place on public disclosure of clinical trials data and information in Europe, the US, ...

Continue Reading →
0

Pugatch Consilium releases new report on National Biotechnology Innovation strategies

Posted by:

Today Pugatch Consilium releases a new report on the development of national innovation strategies in the biotech sector commissioned by the Biotechnology Industry Organization (BIO).

The report, Building the Bioeconomy Examining National Biotechnology Industry Development Strategies, provides an overview of national innovation strategies, policies and best practices that relate to the building of a world-class biotechnology sector. It identifies key enabling policy input factors ranging from human capital, protection of intellectual property to infrastructure for research and development.

Through case ...

Continue Reading →
0

New Report on the Value of Cross-Border Data

Posted by:

Pugatch Consilium has launched a new report, At the Cutting Edge, on the benefits of cross-border data to consumers, companies and governments. The report considers the value and applications of cross-border data in different countries around the world today. It analyzes a wide range of personal, social and economic benefits using case studies and anecdotes as well as statistical analysis. The report also presents a set of enabling and deterrent factors of these flows. Download a copy from the Continue Reading →

0
Page 6 of 15 «...45678...»